Early-stage lung lesions are often small, low contrast, and obscured by surrounding anatomy. On chest radiographs, these findings can be genuinely difficult to distinguish from normal anatomical variations, even with careful review.
In routine health checkup settings, where most patients are asymptomatic, the challenge is not simply identifying disease. It also requires consistently and accurately excluding significant abnormalities across high volumes of imaging studies.
These limitations can result in missed or delayed diagnoses during the stage when treatment is most effective. The clinical impact of overlooking these findings can be substantial. AI-assisted diagnostic support systems may help address this challenge by highlighting suspicious regions on imaging studies and supporting more accurate and confident clinical decision-making.
This case, documented by a radiologist at Phanat Nikhom Hospital, demonstrates how AI-assisted detection can improve diagnostic outcomes.
Inspectra CXR in Annual Health Check-Up Screening
The following case comes from a radiologist at Phanat Nikhom Hospital, a large public hospital in Thailand, using Inspectra CXR as part of a routine annual health check-up program, where most patients present without respiratory complaints.
A 48-year-old woman with no underlying medical conditions and no respiratory symptoms underwent a routine screening chest radiograph. The image showed a subtle abnormality in the left upper lung zone, partially obscured by overlapping structures including the clavicle and first rib, a region known to be anatomically challenging on plain radiography.
Inspectra CXR flagged the region as suspicious, providing an AI-generated overlay that directed attention to the finding and increased diagnostic confidence for further evaluation.
Subsequent CT imaging confirmed a spiculated mass at the apicoposterior segment of the left upper lobe. The patient underwent left upper lobectomy. Histopathological examination identified focal necrotizing granulomatous inflammation with malignant cell clusters demonstrating spread through air spaces (STAS). The final diagnosis was Stage I lung cancer, managed with curative intent.
Lung Cancer Early Detection Challenge
This case illustrates a well-recognized challenge in screening radiology. The patient had no identifiable risk factors and no symptoms, exactly the profile where subtle findings are most likely to be underweighted.
In routine practice, radiologists interpret large numbers of chest X-rays, the majority of which are unremarkable. Maintaining consistent sensitivity across that volume, particularly for findings that are anatomically obscured or low-contrast, is a recognized source of diagnostic variability.
AI, such as Inspectra CXR, functions as a concurrent second reader analyzing each image independently and surfacing areas that warrant closer review. The system does not replace clinical judgment, but provides structured, real-time support to the interpreting physician, particularly in cases where subtle findings carry significant downstream consequences.
In this case, AI-assisted review contributed to an early-stage diagnosis that may not have been identified on initial interpretation alone as a meaningful outcome in a disease where stage at diagnosis is the primary determinant of survival.
About Inspectra CXR
Inspectra CXR is an AI-powered chest X-ray analysis tool developed by Perceptra, trained on 1.9 million chest radiographs with 47% sourced from Asian populations. It detects eight thoracic conditions including lung nodules, masses, and tuberculosis with 98% accuracy. The system integrates directly with PACS/RIS workflows and requires no additional user input at the point of image acquisition.
Inspectra CXR is currently deployed across more than 470 medical centers. For more information, visit Inpsectra CXR
